Gastroenterology & Hepatology

Gastrointestinal Oncology

Researchers are invited to submit abstracts for the "Gastrointestinal Oncology" track at GASTROENTEROLOGY-2024. This track will focus on recent advances in the diagnosis, treatment, and management of gastrointestinal (GI) cancers, encompassing a broad spectrum from esophageal to colorectal malignancies.

Abstract submissions should address innovative strategies in cancer screening, precision medicine approaches, multimodal treatment protocols, and survivorship care in GI oncology. We encourage submissions on biomarker-driven therapies, immunotherapy advancements, surgical innovations, and outcomes research.

What to Expect:

Attendees can expect dynamic sessions featuring leading experts presenting on the latest clinical trials, personalized treatment algorithms, and emerging technologies in GI oncology. The track will delve into multidisciplinary approaches to cancer care, including the integration of radiomics, genomic profiling, and patient-centered care models.

Join us at GASTROENTEROLOGY-2024 to collaborate on advancing the field of GI oncology through transformative research and innovative clinical practices. Engage in discussions that explore the future directions of cancer treatment and survivorship, aiming to improve outcomes and quality of life for patients globally.